AAA

ARCTIC BIOSCIENCE AS

No trades
See on Supercharts
Market capitalization
‪258.77 M‬NOK
‪−45.51 M‬NOK
‪33.75 M‬NOK
‪25.36 M‬
Beta (1Y)
0.77

About ARCTIC BIOSCIENCE AS

CEO
Christer Ludvig Valderhaug
Headquarters
Orsta
Employees (FY)
20
Founded
2011
ISIN
NO0010859580
FIGI
BBG00Z9066Q4
Arctic Bioscience AS engages in the development, manufacturing, and marketing of marine ingredients extracted from herring roe. It develops novel, oral pharmaceutical treatment for mild-to-moderate psoriasis. It also supplies nutraceutical ingredients and finished products for dietary supplements. The company was founded by Hogne Hallaraker, Harald Nordal, and Jan Brevig Remmerelt in 2011 and is headquartered in Orsta, Norway.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ABS is 9.9 NOK — it has decreased by 5.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange ARCTIC BIOSCIENCE AS stocks are traded under the ticker ABS.
ABS stock is 5.58% volatile and has beta coefficient of 0.77. Check out the list of the most volatile stocks — is ARCTIC BIOSCIENCE AS there?
Yes, you can track ARCTIC BIOSCIENCE AS financials in yearly and quarterly reports right on TradingView.
ABS stock has fallen by 5.29% compared to the previous week, the month change is a 2.48% fall, over the last year ARCTIC BIOSCIENCE AS has showed a 8.37% decrease.
ABS net income for the last quarter is ‪−24.85 M‬ NOK, while the quarter before that showed ‪−20.66 M‬ NOK of net income which accounts for −20.26% change. Track more ARCTIC BIOSCIENCE AS financial stats to get the full picture.
Today ARCTIC BIOSCIENCE AS has the market capitalization of ‪263.84 M‬, it has decreased by 3.81% over the last week.
No, ABS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ABS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARCTIC BIOSCIENCE AS stock right from TradingView charts — choose your broker and connect to your account.
ABS reached its all-time high on Mar 12, 2021 with the price of 32.0 NOK, and its all-time low was 7.5 NOK and was reached on Oct 27, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 20.00 employees. See our rating of the largest employees — is ARCTIC BIOSCIENCE AS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARCTIC BIOSCIENCE AS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARCTIC BIOSCIENCE AS stock shows the sell signal. See more of ARCTIC BIOSCIENCE AS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ARCTIC BIOSCIENCE AS future price: according to them, ABS price has a max estimate of 54.00 NOK and a min estimate of 10.00 NOK. Read a more detailed ARCTIC BIOSCIENCE AS forecast: see what analysts think of ARCTIC BIOSCIENCE AS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARCTIC BIOSCIENCE AS EBITDA is ‪−43.20 M‬ NOK, and current EBITDA margin is −128.01%. See more stats in ARCTIC BIOSCIENCE AS financial statements.